Status:
UNKNOWN
Establishing Clinical Utility Evidence for Chronic Disease Management Testing
Lead Sponsor:
Qure Healthcare, LLC
Conditions:
Cardiometabolic Syndrome
Eligibility:
All Genders
Phase:
NA
Brief Summary
This is a national-level research study of primary care physicians. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling and other) of a subset o...
Detailed Description
The results of this study could contribute to improved quality of care for patients by encouraging better care practices and adherence to evidence-based guidance. The data from this study will be subm...
Eligibility Criteria
Inclusion
- Subjects must meet the following criteria to be enrolled in the study:
- Board-certified physician currently practicing in the following areas:
- Internal medicine
- Family medicine
- Have practiced as a board-certified physician in internal or family medicine or greater than 2 but less than 30 years
- Community / non-academic based practice setting
- ≥ 40 patients under care weekly
- Commonly treats patients with atrial fibrillation, coronary artery disease, congestive heart failure, diabetes, hypertension, and hyperlipidemia
- Practicing in the U.S.
- English-speaking
- Access to the internet
- Informed and voluntarily consented to be in the study
Exclusion
- Non-English speaking
- Practicing in an academic setting
- Unable to access the internet
- Not practicing in the U.S.
- Do not voluntarily consent to be in the study
Key Trial Info
Start Date :
October 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 22 2023
Estimated Enrollment :
249 Patients enrolled
Trial Details
Trial ID
NCT05192590
Start Date
October 22 2021
End Date
February 22 2023
Last Update
December 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QURE Healthcare
San Francisco, California, United States, 94109